Tue, May 5, 2020

Gena Wang Upgraded (BCRX) to Buy and Increased Target to $7 on, May 5th, 2020

Gena Wang of Barclays, Upgraded "BioCryst Pharmaceuticals, Inc." (BCRX) to Buy and Increased Target from $4 to $7 on, May 5th, 2020.

Gena, nor any peers, have made any analyst calls on BCRX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30